Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Multianalyte Quality Control Introduced for NAT Labs

By LabMedica International staff writers
Posted on 27 Apr 2009
A liquid stable, unassayed, multianalyte, third party quality control is available for nucleic acid testing (NAT) labs.

The product, called AmpliTrol III, was designed for use with qualitative in vitro diagnostic procedures for the detection of Human Immunodeficiency Virus, Type 1 (HIV-1), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) nucleic acids in human serum or plasma. More...
The new configuration of AmpliTrol III has 60-day open-vial stability when stored at 2-8 ºC. Routine use provides laboratories with the means to monitor assay performance and assure quality on an ongoing basis.

Introduced by Bio-Rad (Hercules, CA, USA), AmpliTrol III is a full process positive control used in the same manner as a patient specimen to monitor sample preparation, amplification, and detection procedures. It is compatible with many commercially available NAT systems, including the Roche (Basel, Switzerland) Cobas AmpliScreen HIV-1 v1.5, Roche AmpliScreen HBV, Roche AmpliScreen HCV v2.0, and Chiron (Emeryville, CA, USA) Procleix HIV-1/HCV assays.

Bio-Rad Laboratories, Inc. is a manufacturer and distributor of life science clinical diagnostics and research products.

Related Links:

Bio-Rad
Roche
Chiron



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Host Response Immunoassay Test
MeMed BV
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.